ArticleInternational journal of molecular sciences2025
Feasibility Assessment of Autologous Human Immune System (HIS) ImmunoGraft Platform Development Using Autologous Mobilized Peripheral Blood (MPB) CD34 Cells Derived from Adult HNSCC Patient.
Bhavna Verma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.